Ceva Animal Health
Ceva Animal Health US provides innovative health solutions for companion animals, poultry, and swine in America.
Last updated September 1, 2026
Overview
Ceva Animal Health US is the American arm of Ceva Santé Animale, a global animal health company. It focuses on delivering innovative vaccines, therapeutics, and behavioral health solutions for companion animals, poultry, and swine in the United States. The company has a strong U.S. presence in research, manufacturing, and field support.
History
Ceva was founded in 1999 and has become one of the fastest growing animal health companies in the world. Since 2000, Ceva has completed more than 30 successful business integrations. In the United States, Ceva has expanded through acquisitions and launches, including the acquisition of Scout Bio in 2024, the opening of a genomics center in 2023, the launch of CARDALIS® in 2021, and the acquisition of THUNDERWORKS® in 2019.
Products and positioning
CARDALIS®
A product containing spironolactone and benazepril, used in cardiology.
FELIWAY® OPTIMUM
A pheromone product with a patented formula that mimics natural cat pheromones to help cats with signs of stress.
THUNDERWORKS®
A product in Ceva's behavior range.
Flagship businesses
- CARDALIS®
- FELIWAY® OPTIMUM
- THUNDERWORKS®
Sources
Cite this profile: Cite the canonical profile. /brand-wiki/ceva-animal-health-us · Editorial policy · How profiles are compiled